The Riluzole Early Access Programme: descriptive analysis of 844 patients in France
- 1 May 1997
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 244 (2) , S22-S25
- https://doi.org/10.1007/bf03160577
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Riluzole and amyotrophic lateral sclerosisThe Lancet, 1996
- Dose-ranging study of riluzole in amyotrophic lateral sclerosisThe Lancet, 1996
- El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Onset, natural history and outcome in idiopathic adult motor neuron diseaseJournal of the Neurological Sciences, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Survival prediction in amyotrophic lateral sclerosisMuscle & Nerve, 1989